April 11 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS STRENGTHENS POSITION IN AUTOIMMUNE
DISEASE
WITH STRATEGIC PIPELINE EXPANSION SUPPORTED BY $60 MILLION
PRIVATE PLACEMENT AND ACQUISITION OF CLADE THERAPEUTICS
* CENTURY THERAPEUTICS INC - PRIVATE PLACEMENT OF $60
MILLION LED
BY BAIN CAPITAL LIFE SCIENCES SUPPORTS EXPANSION IN AUTOIMMUNE
DISEASE
* CENTURY THERAPEUTICS INC - PRIVATE PLACEMENT REINFORCING
CASH
RUNWAY INTO 2026
* CENTURY THERAPEUTICS INC - TO INITIATE CALIPSO-1 SLE TRIAL
H1
2024
* CENTURY THERAPEUTICS INC: PLANS TO PURSUE ADDITIONAL
AUTOIMMUNE
DISEASE INDICATION REGULATORY FILINGS IN 2024
Source text for Eikon: ID:nGNX53tLyt
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))